View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
David Nierengarten ... (+3)
  • David Nierengarten
  • Dennis Pak
  • Martin Fan
Wedbush Research
  • Wedbush Research
David Nierengarten ... (+8)
  • David Nierengarten
  • Dennis Pak
  • Dylan Shindler
  • Laura Chico
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Yun Zhong
David Nierengarten ... (+3)
  • David Nierengarten
  • Dennis Pak
  • Martin Fan
 PRESS RELEASE

Compass Diversified Declares First Quarter 2025 Distributions on Commo...

Compass Diversified Declares First Quarter 2025 Distributions on Common and Series A, B and C Preferred Shares WESTPORT, Conn., April 03, 2025 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded consumer and industrial businesses, announced today that its Board of Directors (the “Board”) has declared a quarterly cash distribution of $0.25 per share on the Company’s common shares (the “Common Shares”). The distribution for the three months ended March 31, 2025, is payable on April 24, 2025, to all holders of record of Co...

 PRESS RELEASE

Compass Diversified Announces Appointment of Matthew Blake as CEO of A...

Compass Diversified Announces Appointment of Matthew Blake as CEO of Arnold Magnetics WESTPORT, Conn., April 01, 2025 (GLOBE NEWSWIRE) -- Compass Diversified Holdings (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market branded consumer and industrial businesses, today announced that Matthew Blake has been named Chief Executive Officer of its subsidiary, Arnold Magnetic Technologies Corporation (“Arnold”), a leading global manufacturer of high-performance electric motors, magnets, and thin metals, effective March 31, 2025. Concurrent with his appointment, Blake will j...

Wedbush Research
  • Wedbush Research
David Nierengarten ... (+8)
  • David Nierengarten
  • Dennis Pak
  • Dylan Shindler
  • Laura Chico
  • Martin Fan
  • Ritika Das
  • Robert Driscoll
  • Yun Zhong
 PRESS RELEASE

THOR Industries Announces Regular Quarterly Dividend

THOR Industries Announces Regular Quarterly Dividend ELKHART, Ind., March 25, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that its Board of Directors approved, at its March 25, 2025, meeting, the payment of a regular quarterly cash dividend of $0.50 per share. The regular cash dividend is payable on April 22, 2025, to shareholders of record at the close of business on April 8, 2025. About THOR Industries, Inc. THOR is the sole owner of operating companies which, combined, represent the world's largest manufacturer of recreational vehicles. For more infor...

 PRESS RELEASE

THOR Announces Strategic Realignment of Heartland Recreational Vehicle...

THOR Announces Strategic Realignment of Heartland Recreational Vehicle Company ELKHART, Ind., March 19, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO), the global leader in the recreational vehicle (RV) industry, today announced a strategic organizational restructuring aimed at optimizing its enterprise structure and strengthening its brand portfolio. As part of this realignment, Heartland Recreational Vehicles will now be integrated under Jayco, Inc., enhancing operational efficiencies and streamlining business processes. Bob Martin, President and Chief Executi...

 PRESS RELEASE

THOR Industries Announces Second Quarter Fiscal 2025 Results

THOR Industries Announces Second Quarter Fiscal 2025 Results POISED FOR A MARKET RETURN Fiscal 2025 Second Quarter Highlights                        ($ in thousands, except for per share data)Three Months Ended January 31, Change  Six Months Ended January 31, Change  2025   2024     2025   2024  Net Sales$2,018,107  $2,207,369  (8.6)%  $4,160,891  $4,708,128  (11.6)%Gross Profit$245,197  $270,847  (9.5)%  $526,639  $628,779  (16.2)%Gross Profit Margin % 12.1%  12.3% (20) bps    12.7   13.4  (70) bps Net Income (Loss) Attributable to THOR$(551) $7,217  (107.6)%  $(2,383) $60,782  (103.9)%Dil...

Novocure Ltd: 6 directors

Six Directors at Novocure Ltd sold 37,559 shares at between 18.751USD and 20.024USD. The significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...

 PRESS RELEASE

Novocure to Participate in Leerink Partners 2025 Global Healthcare Con...

BAAR, Switzerland--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR) announced today that management will participate in the Leerink Global Healthcare Conference on Tuesday, March 11, 2025. Christoph Brackmann, Chief Financial Officer, will take part in a fireside chat at 4:20 p.m. EST, as well as one-on-one meetings with investors throughout the event. A live audio webcast of this presentation can be accessed from the Investor Relations page of Novocure’s website, , and will be available for replay for at least 14 days following the event. About Novocure Novocure is a global oncology company wo...

 PRESS RELEASE

THOR Industries Announces Participation in Upcoming Investor Conferenc...

THOR Industries Announces Participation in Upcoming Investor Conferences ELKHART, Ind., March 03, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that its management team will be participating in two upcoming investor conferences. THOR management will be hosting fireside chats along with one-on-one meetings with analysts and institutional investors at the following events: Citi’s Global Consumer & Retail Conference on March 10, 2025 in Aventura, Florida. Management in attendance will include: Todd Woelfer, Senior Vice President and COO of THOR Industries The ...

Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
O REALTY INCOME CORPORATION
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
LOW LOWE'S COMPANIES INC.
KURA KURA ONCOLOGY INC.
HD HOME DEPOT INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CRM SALESFORCE.COM INC.
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
BBY BEST BUY CO. INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
AAP ADVANCE AUTO PARTS INC.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
EPRT ESSENTIAL PROPERTIES REALTY TRUST
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
PLTR PALANTIR TECHNOLOGIES
VRDN VIRIDIAN THERAPEUTICS INC
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
FNMA FEDERAL NATIONAL MORTGAGE ASSOCIATION
ELEV ELEVATION ONCOLOGY
APP APPLOVIN CORP
UWMC UWM HLDGS CORP
ATXS ASTRIA THERAPEUTICS INC
AVTE AEROVATE THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
NTST NETSTREIT CORP
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
BNL BROADSTONE NET LEASE INC
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch